HIV in women: Consistent use of vaginal ring provides significant protection against HIV

When used consistently for a month at a time, a vaginal ring containing an antiretroviral (ARV) drug called dapivirine provides significant protection against HIV, suggest results of new data analyses from the ASPIRE study announced today at The International Conference on AIDS (AIDS 2016) in Durban, South Africa. Among women who appeared to use the ["]